Ntrk3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Property |
Value |
| Protein Name |
Neurotrophic receptor tyrosine kinase 3 (TrkC) |
| Gene |
NTRK3 Gene |
| UniProt ID |
Q15006 |
| Molecular Weight |
93000 Da |
| Subcellular Location |
Cell membrane, neuron dendrites |
| Protein Family |
Trk family (NTRK1/2/3) |
TrkC is a member of the neurotrophic tyrosine kinase receptor family and serves as the high-affinity receptor for neurotrophin-3 (NT-3). It is a transmembrane receptor with intrinsic tyrosine kinase activity.
Structural features:
- Extracellular ligand-binding domain with leucine-rich repeats (LRR) and Ig-like domains
- Single transmembrane helix
- Intracellular tyrosine kinase domain
- Forms homodimers upon ligand binding
Molecular function:
- NT-3 binding and signal transduction
- Activation of PI3K/Akt, MAPK/ERK, and PLCγ pathways
- Neuronal survival signaling
- Synaptic plasticity modulation
- Axonal guidance during development
Neurodevelopmental disorders: Loss-of-function mutations impair neuronal development, leading to intellectual disability, autism, and speech delays.
Congenital insensitivity to pain: Mutations disrupt nociceptive neuron development, causing inability to feel pain while preserving touch and proprioception.
Alzheimer's disease: NT-3/TrkC signaling is reduced in AD brains. Activation protects against Aβ-induced neuronal death.
Parkinson's disease: TrkC signaling promotes dopaminergic neuron survival. NT-3 delivery has shown neuroprotective effects in models.
- NT-3 analog: Pabina, being investigated for neuropathy
- TrkC agonists: Small molecules in development
- Gene therapy: AAV-NT-3 being studied for PD and AD
- Cell therapy: NT-3 secreting stem cells in trials
TrkC exhibits specific expression patterns in the nervous system:
- Hippocampus: High expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells
- Cerebral cortex: Layer-specific expression in cortical pyramidal neurons
- Cerebellum: Purkinje cells and granule cells
- Brainstem: Motor nuclei and sensory relay neurons
- Spinal cord: Motor neurons and interneurons
- Sensory neurons: Dorsal root ganglion (DRG) neurons
- Autonomic ganglia: Sympathetic and parasympathetic neurons
- Neural crest derivatives: Various peripheral nervous system structures
- Highest during embryonic development
- Gradual decline postnatally but maintained in specific populations
- Plasticity-induced re-expression in adults following injury
¶ Ligand Binding and Activation
NT-3 binding to TrkC triggers multiple downstream signaling cascades:
| Pathway |
Key Molecules |
Primary Functions |
| PI3K/Akt |
PI3K, Akt, mTOR |
Cell survival, protein synthesis, metabolism |
| MAPK/ERK |
Ras, Raf, MEK, ERK |
Neurite outgrowth, differentiation, plasticity |
| PLCγ |
PLCγ, DAG, IP3, Ca²⁺ |
Synaptic plasticity, gene transcription |
- Ligand-bound TrkC is internalized via clathrin-mediated endocytosis
- Internalized receptors can continue signaling in endosomes
- Receptor trafficking regulates signal duration and specificity
- Lysosomal degradation terminates signaling
Cell Survival Molecules:
- Bcl-2 family proteins (Bcl-2, Bcl-xL)
- Caspase inhibitors
- XIAP
Transcriptional Regulators:
- CREB (cAMP response element-binding protein)
- NF-κB
- c-Fos, c-Jun
Cytoskeletal Regulators:
- MAP2 (microtubule-associated protein)
- Tau phosphorylation regulators
- Synapsin I
TrkC signaling protects neurons through multiple anti-apoptotic mechanisms:
- Bcl-2 upregulation: NT-3/TrkC signaling increases expression of anti-apoptotic Bcl-2 family proteins
- Caspase inhibition: Direct and indirect inhibition of caspase-3 and caspase-9
- Mitochondrial protection: Maintains mitochondrial membrane potential
- DNA repair enhancement: Activates DNA repair mechanisms
- Upregulation of antioxidant enzymes (SOD, catalase)
- Reduction of reactive oxygen species (ROS)
- Protection against mitochondrial dysfunction
- Modulation of microglial activation
- Reduction of pro-inflammatory cytokine release
- Protection against neuroinflammation-mediated damage
- NT-3/TrkC signaling protects against Aβ-induced neurotoxicity
- Promotes hippocampal synaptic plasticity
- May enhance memory consolidation
- Clinical trials with NT-3 for AD have shown promise
- TrkC activation protects dopaminergic neurons
- NT-3 delivery reduces 6-OHDA-induced damage
- Gene therapy approaches in development
- Combined with other neurotrophic factors
- Protects motor neurons
- Promotes neuromuscular junction stability
- May slow disease progression
- Combined approaches with BDNF being explored
- NT-3 reverses sensory neuropathy in models
- Being developed for diabetic neuropathy
- Promotes nerve regeneration after injury
- Promotes axonal regeneration
- Improves functional recovery in models
- Combined with rehabilitation approaches
| Drug/Agent |
Type |
Stage |
Indication |
| Pabina |
NT-3 recombinant protein |
Preclinical |
Neuropathy |
| AAV-NT-3 |
Gene therapy |
Phase I/II |
AD, PD |
| Small molecule TrkC agonists |
Synthetic |
Preclinical |
Various |
| NT-3 secreting stem cells |
Cell therapy |
Preclinical |
SCI |
- Blood-brain barrier penetration
- Receptor specificity
- Dosing optimization
- Long-term safety
- Delivery methods
- TrkC knockout mice: Severe neurological deficits, die perinatally
- Heterozygous mice: Viable with subtle defects
- Conditional knockouts: Region-specific insights
- NT-3 overexpression: Enhanced neuroprotection
- Constitutively active TrkC: Insights into signaling
- 6-OHDA lesioned rats (PD)
- Aβ-injected mice (AD)
- SOD1 transgenic mice (ALS)
- TrkC expression in CSF as neuronal health indicator
- Soluble TrkC (sTrkC) as biomarker
- NT-3 levels in blood/CSF
- Not established for diagnosis
- May predict treatment response
- Could monitor disease progression
- Combination therapies: NT-3 with other neurotrophic factors
- Targeted delivery: Nanoparticle, exosome-based delivery
- Blood-brain barrier modulation: Enhanced CNS delivery
- Personalized medicine: Genetic subtypes affecting response
- Optimal delivery route and timing
- Long-term effects of sustained activation
- Mechanisms of signal termination
- Interaction with disease-specific pathology
The study of Ntrk3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.